
    
      A multinational, multicenter, randomized, comparative, open-label, phase 3 study

      Primary Objective: To assess the vaccine response rates after the three-dose primary
      vaccination Secondary Objectives: To measure the antibody titer after the three-dose primary
      vaccination and to assess the safety of the investigational products
    
  